Status:
COMPLETED
Improving Medication Adherence Among People With Schizophrenia Through the Use of 2-way Pagers
Lead Sponsor:
Northwell Health
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Schizophrenia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will determine whether using a pager improves medication adherence in people with schizophrenia.
Detailed Description
Schizophrenia is a life-long brain disorder affecting approximately 1 percent of Americans each year. Schizophrenia can be extremely disabling, causing people to hear voices, experience paranoia or ha...
Eligibility Criteria
Inclusion
- Meets DSM-IV criteria for schizophrenia or schizoaffective disorder
- Admitted to the Zucker Hillside Hospital for exacerbation of illness
- Speaks English
Exclusion
- Presence of severe visual or motor impairments
- Mental retardation
- Neurologic disorder that may impact functioning such as seizures or vascular, neoplastic, traumatic, or infectious disorders affecting the brain
- Prescribed a psychotropic drug in depot form
- After hospital discharge, a living or treatment situation that includes dispensing of full medication regimen
Key Trial Info
Start Date :
April 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT00392236
Start Date
April 1 2006
End Date
December 1 2009
Last Update
October 25 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Zucker Hillside Hospital
Glen Oaks, New York, United States, 11004